<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1212</ReferenceId>
        <DateLastUpdated>2020-10-11-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15186860</PubmedId>
            <Abstract>The peptides DRPVPY and MDWNMHAA, which were identified as mimics of the cell-surface polysaccharides of Streptococcus Group A and Shigella flexneri Y, respectively, were used in this study to develop experimental vaccines directed against these two bacteria. Both oligopeptides were synthesized employing the Fmoc solid-phase strategy and linked via the amino end to a bifunctional linker, diethylsquarate. These adducts were then conjugated to the two carrier proteins, bovine serum albumin (BSA) and tetanus toxoid (TT) to yield the peptide conjugate vaccines. The average level of incorporation of DRPVPY and MDWNMHAA on TT was 65% and 75%, respectively, whereas that of both peptide haptens on BSA was 100%. A polysaccharide conjugate against S. flexneri Y, which comprises about 10 tetrasaccharide repeating units, was also prepared based on reductive amination at the reducing end with 1,3-diaminopropane, followed by coupling of the aminated polysaccharide to diethylsquarate, and subsequent coupling of the adduct to TT. An average incorporation of 73% of polysaccharide haptens was achieved. The glycoconjugate and the oligopeptide conjugates were shown to bind effectively to the respective monoclonal antibodies directed against the cell-surface polysaccharides.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>3743-54</ArticlePages>
            <ArticleTitle>Synthesis and immunochemical characterization of protein conjugates of carbohydrate and carbohydrate-mimetic peptides as experimental vaccines.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Hossany</LastName>
                    <ForeName>Rehana B</ForeName>
                </Author>
                <Author>
                    <LastName>Johnson</LastName>
                    <ForeName>Margaret A</ForeName>
                </Author>
                <Author>
                    <LastName>Eniade</LastName>
                    <ForeName>Adewale A</ForeName>
                </Author>
                <Author>
                    <LastName>Pinto</LastName>
                    <ForeName>B Mario</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada V5A 1S6.</Affiliations>
            <ArticleChemicalList>Antibodies;Antigens;Carbohydrates;Glycoconjugates;Lipopolysaccharides;Peptides;Proteins;Vaccines</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Antibodies(immunology); Antigens(immunology); Biomimetic Materials(chemical synthesis; chemistry); Carbohydrate Sequence; Carbohydrates(chemistry; immunology); Glycoconjugates(chemistry; immunology); Inhibitory Concentration 50; Lipopolysaccharides(immunology); Peptides(chemical synthesis; chemistry; immunology); Proteins(chemistry; immunology); Shigella flexneri(chemistry; immunology); Streptococcus pyogenes(chemistry; immunology); Vaccines(chemical synthesis; chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>12</Volume>
                <Issue>13</Issue>
                <Title>Bioorganic &amp; medicinal chemistry</Title>
                <Issn>1464-3391</Issn>
                <MedlineTa>Bioorg Med Chem</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>MDWNMHAA</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>MDWNMHAA</LinearSequence>
                        <ModifiedResidues>A8</ModifiedResidues>
                        <Modifications>Amidation|AMID</Modifications>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalNonSequenceMolecule>
                            <ChemicalType>Carbohydrate fragment</ChemicalType>
                            <Molecule>
                                <ChEBIId>CHEBI:59299</ChEBIId>
                            </Molecule>
                            <SourceMolecule>
                                <ChEBIId>CHEBI:16412</ChEBIId>
                            </SourceMolecule>
                            <SourceOrganismId>424720</SourceOrganismId>
                        </FragmentOfANaturalNonSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Abstract</LocationOfData>
                <EpitopeId>126667</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Peptide was synthesized as H-MDWNMHAA-NH2 since an amide functionality was desired at the C-termini for conjugation to linker molecule. It has been previously identified from a phage display library of octapeptides as a binder of anti-S.flexneri Y O-PS mAb SYA/J6.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table I</LocationOfData>
                        <BCellId>17771</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>424720</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The monoclonal antibody was produced following hyper-immunization with a killed, whole cell vaccine of S.flexneri Y.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>311</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Peptide-linker-BSA and Peptide-linker-Tetanus Toxoid (Linker molecule  is the bifunctional linker diethylsquarate) conjugates are able to inhibit binding of SYA/J6 mAb to Y.flexneri LPS, with similar IC50 of 2.2 and 2.5 uM, respectively. This is an improvement on the IC50 for the free peptide (19 uM for the cognate peptide and 33.5 uM for the similar peptide H-MDWNMHAA-NH2) implying multivalent display of the peptide in the conjugates could result in greater antigenicity. By comparison, the mimicked molecule, tetrasaccharide-linker-BSA conjugate has a IC50 of 1.1 uM, roughly comparable to that of free tetrasaccharide.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>SYA/J6</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG3</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <SequenceMoleculeNoNaturalSource>
                                        <ChemicalType>Peptide, no natural source</ChemicalType>
                                        <LinearSequence>MDWNMHAA</LinearSequence>
                                        <ModifiedResidues>A8</ModifiedResidues>
                                        <Modifications>Amidation|AMID</Modifications>
                                    </SequenceMoleculeNoNaturalSource>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Tetrasaccharide from O-PS of S.flexneri variant Y</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalNonSequenceMolecule>
                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59299</ChEBIId>
                        </Molecule>
                        <SourceMolecule>
                            <ChEBIId>CHEBI:16412</ChEBIId>
                        </SourceMolecule>
                        <SourceOrganismId>424720</SourceOrganismId>
                    </FragmentOfANaturalNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>127514</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is part of the repeat unit of the O-PS from S.flexneri Y LPS.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table I</LocationOfData>
                        <BCellId>18244</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>424720</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The monoclonal antibody was produced following hyper-immunization with a killed, whole cell vaccine of S.flexneri Y.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>311</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The unconjugated 10 repetitive units of the epitope (not just one as depicted here) is able to inhibit binding of SYA/J6 mAb to Y. flexneri LPS, with similar IC50 than sacccaharide-linker(squarate)-TT conjugate, with a conjugation ratio of 44 epitope-linker molecules per TT molecule.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>SYA/J6</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG3</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59299</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>424720</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Imperfect match</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>DRPVPY</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>DRPVPY</LinearSequence>
                        <ModifiedResidues>Y6</ModifiedResidues>
                        <Modifications>Amidation|AMID</Modifications>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalNonSequenceMolecule>
                            <ChemicalType>Carbohydrate fragment</ChemicalType>
                            <Molecule>
                                <ChEBIId>CHEBI:59308</ChEBIId>
                            </Molecule>
                            <SourceMolecule>
                                <ChEBIId>CHEBI:18154</ChEBIId>
                            </SourceMolecule>
                            <SourceOrganismId>1314</SourceOrganismId>
                        </FragmentOfANaturalNonSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Abstract</LocationOfData>
                <EpitopeId>125843</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Peptide was synthesized as H-DRPVPY-NH2 since an amide functionality was desired at the C-termini for conjugation to linker molecule. Its has been previously identified from a phage display library of peptides as a binder of anti-Group A Streptococcus polysaccharide mAb SA-3.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <BCellId>18250</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10001465</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice (A/J or Balb/C) were immunized with a pepsin-treated cell wall vaccine. Immunization is described in Reimer et al, Carbohydr Res. 1992 232(1):131 [PMID: 1423345].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Peptide-linker(diethylsquarate)-BSA and Peptide-linker-TT (tetanus toxin) conjugates are able to bind SA-3 mAb  similarly and the signal is comparable to that of the mimicked saccharide-linker-TT.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>SA-3</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <SequenceMoleculeNoNaturalSource>
                                        <ChemicalType>Peptide, no natural source</ChemicalType>
                                        <LinearSequence>DRPVPY</LinearSequence>
                                        <ModifiedResidues>Y6</ModifiedResidues>
                                        <Modifications>Amidation|AMID</Modifications>
                                    </SequenceMoleculeNoNaturalSource>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Pentasaccharide fragment B(C)A'B'A</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalNonSequenceMolecule>
                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59308</ChEBIId>
                        </Molecule>
                        <SourceMolecule>
                            <ChEBIId>CHEBI:18154</ChEBIId>
                        </SourceMolecule>
                        <SourceOrganismId>1314</SourceOrganismId>
                    </FragmentOfANaturalNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>127513</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Pentasaccharide from the repetitive unit of Group A Streptococcus cell wall polysaccharide.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <BCellId>18251</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10001465</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice (A/J or Balb/C) were immunized with a pepsin-treated cell wall vaccine. Immunization is described in Reimer et al, Carbohydr Res. 1992 232(1):131 [PMID: 1423345].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Pentasaccharide-linker-TT (tetanus toxin) conjugate is able to bind SA-3 mAb. A conjugation ratio of 23 epitope-linker (squarate) molecules per toxin molecule was achieved.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>SA-3</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59308</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:18154</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1314</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>AAA23282.1</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>1513</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

